Condition
GIST clinical trials and research
As of November 12, 2026, Find a Trial lists 9 GIST clinical trials that are recruiting, at sites in 9 countries (most in United States (4), France (2), China (2)). By phase: Phase 1 (1), Phase 1/2 (1), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 9Countries
Newest GIST clinical trials
All recruiting trials (9)
-
GIST Patient Registry for real-world insights
This registry collects medical information from people with GIST to see how the disease behaves in real life and to help improve care.
-
Comparing EFTR versus STER for removing small gastric GISTs
This trial will test whether endoscopic full-thickness resection (EFTR) or submucosal tunneling endoscopic resection (STER) is better at completely removing small (1.0–3.5 cm) gastric GISTs in adults.
-
KQB198 plus imatinib for first-line advanced or metastatic GIST
This Phase 2 test will see if adding the experimental drug KQB198 to imatinib helps people with advanced or metastatic GIST who are starting first-line treatment.
-
Lenvatinib for advanced GIST after imatinib, sunitinib, and regorafenib
This trial tests whether the oral drug lenvatinib can help people with metastatic or advanced GIST whose disease has progressed on imatinib, sunitinib, and regorafenib.
-
Olverembatinib for treating SDH-deficient GIST
This study is testing if a new medication called olverembatinib can help people with a specific type of gastrointestinal tumor feel better after they’ve already tried one other treatment.
-
Lutetium Lu 177 Edotreotide dose-finding for children with SSTR-positive tumors
This test gives Lutetium Lu 177 Edotreotide to children ages 2 to under 18 with somatostatin receptor–positive tumors to find a safe pediatric dose and see how the drug behaves in the body.
-
Long-term outcomes of endoscopic procedures for upper gastrointestinal cancers
This study looks at how well certain endoscopic procedures work for treating larger upper gastrointestinal cancers and what the long-term results are for patients.
-
Monitoring targeted therapy drugs in patients with advanced digestive cancers
This study is testing how to best monitor and adjust the doses of targeted therapy drugs for people with advanced digestive cancers to make sure they are safe and effective.
-
Investigating genetic factors in childhood cancer
This study is trying to find out if certain genes passed down in families can increase the risk of childhood cancer by looking at samples from kids who have had cancer and their relatives.
Related topics
Quick answers
How many GIST clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (4 trials), France (2 trials), China (2 trials), Spain (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.